Thermo Fisher Scientific has good revenue and margin growth prospects ahead and is trading at a discount. See why TMO stock ...

Thermo Fisher Scientific Inc. is proposing to build a new “corporate hangar and office facility” at the Portsmouth ...

At ASHG, Seer showcased its Proteograph product suite which it claims delivers proteomic ... Seer also announced a ...

(Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced a co-marketing and sales agreement with Thermo Fisher Scientific, the world ...

We recently compiled a list of the 10 Best Low Volatility Stocks to Invest in Now. In this article, we are going to take a ...

Aristotle Atlantic Partners, LLC, an investment advisor, released its “Focus Growth Strategy” third quarter 2024 investor ...

We recently made a list of UBS’ Best Stocks In The AI, Growth & Low Rates Era: Top 29 US Stocks. In this piece, we will take ...

The European market for life science tools and reagents and COVID-19 diagnostics products was valued at $14.7 billion in 2023. The market is expected to grow from $13.0 billion in 2024 to $15.4 ...

and they were basically flat at its Laboratory and Product Services segment. Thermo Fisher boosted the low end of its full-year adjusted EPS outlook. Shares of Thermo Fisher Scientific (TMO ...

Laboratory Products and Services: I project the segment will grow by 9%, in line with historical trends. As such, I calculate Thermo Fisher Scientific’s revenue will grow by 9% organically.

The US Food and Drug Administration granted clearances for various tests for infectious diseases, coagulation disorders, and drug susceptibility.

Thermo Fisher Scientific TMO is preparing to release ... analytical technologies (17% of sales); specialty diagnostic products (10%); life science solutions (23%); and lab products and services ...